• Association Between Amygdala Volume and Trajectories of Neuropsychiatric Symptoms in Alzheimer’s Disease and Dementia With Lewy Bodies 

      Jaramillo-Jiménez, Alberto; Melvær, Giil Lasse; Tovar-Rios, Diego Alejandro; Borda, Miguel Germán; Ferreira, Daniel; Brønnick, Kolbjørn Kallesten; Oppedal, Ketil; Aarsland, Dag (Journal article; Peer reviewed, 2021)
      Introduction: The amygdala is implicated in psychiatric illness. Even as the amygdala undergoes significant atrophy in mild dementia, amygdala volume is underexplored as a risk factor for neuropsychiatric symptoms ...
    • Benzodiazepines and antidepressants: Effects on cognitive and functional decline in Alzheimer's disease and Lewy body dementia 

      Borda, Miguel Germán; Jaramillo-Jiménez, Alberto; Oesterhus, Ragnhild; Santacruz, José Manuel; Tovar-Rios, Diego Alejandro; Sønnesyn, Hogne; Cano-Gutierrez, Carlos Alberto; Vik‐Mo, Audun Osland; Aarsland, Dag (Journal article; Peer reviewed, 2021-12-31)
      Objectives We aim to study the effects of the prescription of benzodiazepines and antidepressants on cognitive and functional decline in older adults living with Alzheimer's disease (AD) and Lewy body dementia (LBD) over ...
    • Preanalytical stability of plasma biomarkers for Alzheimer's disease pathology 

      Sunde, Anita Lenora; Alsnes, Ingvild Vatten; Årsland, Dag; Ashton, Nicholas J.; Tovar-Rios, Diego Alejandro; De Santis, Giovanni; Blennow, Kaj; Zetterberg, Henrik; Kjosavik, Svein Reidar (Journal article; Peer reviewed, 2023)
      Introduction Plasma tests have demonstrated high diagnostic accuracy for identifying Alzheimer's disease pathology. To facilitate the transition to clinical utility, we assessed whether plasma storage duration and ...